Hot Flashes

• EMA approval · 2026-08-21
  EMA Authorised: Veoza (fezolinetant) — Astellas Pharma Europe B.V.

  Authorised European marketing approval for Veoza (fezolinetant) by Astellas Pharma Europe B.V. for menopause-related hot flashes.

• FDA approval · 2024-02-15
  FDA Approved: BIJUVA — Supplemental Application (Mayne Pharma)

  The FDA approved a supplemental application for BIJUVA, a combination of estradiol and progesterone, submitted by Mayne Pharma. The approval…